This inventor holds 6 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, E. R. Squibb Sons, Inc.. Active years: 1992-2003.
Location History:
- Merseyside, GB (1992 - 1995)
- Wirral, GB (2000)
- Barnston, GB (2002 - 2003)
Company Filing History:
Years Active: 1992-2003
Title: The Innovations of Andrew B Dennis: Pioneering Controlled Release Delivery Systems
Introduction
Andrew B Dennis, an accomplished inventor based in Barnston, GB, has made significant contributions to the field of pharmaceutical sciences. With a total of six patents to his name, Dennis has focused on developing innovative delivery systems to enhance the efficacy of high solubility pharmaceuticals, such as metformin HCl, to better manage conditions like diabetes.
Latest Patents
Among his latest inventions, Dennis has developed a method of use for a biphasic controlled release delivery system designed specifically for high water solubility pharmaceuticals. This innovative system allows for prolonged gastric residence, thereby enabling a once-daily dosing regimen of at least one gram of metformin while efficiently controlling plasma glucose levels. The unique delivery system comprises two key components: an inner solid particulate phase consisting of uniform granules that incorporate a high water-soluble pharmaceutical along with various polymers, and an outer solid continuous phase that provides structural support and facilitates the delivery of the medication in tablet or capsule form. Additionally, methods for creating and applying this biphasic system in diabetes treatment have also been outlined in his recent patents.
Career Highlights
Throughout his career, Andrew B Dennis has worked with renowned companies, including Bristol-Myers Squibb Company and E.R. Squibb & Sons, Inc. His experiences within these organizations have undoubtedly shaped his innovative approach to pharmaceutical development, allowing him to apply his knowledge towards creating impactful solutions in the healthcare industry.
Collaborations
Dennis collaborated with notable individuals like Peter Timmins and Kiren A Vyas, contributing to a collaborative environment that fosters creativity and innovation. Their joint efforts have played a pivotal role in advancing pharmaceutical research and development.
Conclusion
Andrew B Dennis continues to be a prominent figure in the realm of pharmaceutical inventions. With his dedication to improving drug delivery systems and enhancing treatment protocols for diabetes, his work exemplifies the vital role of innovation and collaboration in transcending current pharmaceutical challenges. As he forges ahead in his inventive endeavors, his contributions will undoubtedly leave a lasting impact on the industry.